Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 15;64(5):209-216.
doi: 10.1002/jlcr.3901. Epub 2021 Jan 19.

Production of [89 Zr]Oxinate4 and cell radiolabeling for human use

Adriana V F Massicano  1 , Jennifer L Bartels  1 , Charlotte D Jeffers  1 , Bryant K Crenshaw  1 , Hailey Houson  1 , Christina Mueller  2 , Jarred W Younger  2 , Paul Knapp  3 , Jonathan E McConathy  1 , Suzanne E Lapi  1
Affiliations

Production of [89 Zr]Oxinate4 and cell radiolabeling for human use

Adriana V F Massicano et al. J Labelled Comp Radiopharm. .

Abstract

[89 Zr]Oxinate4 is a Positron Emission Tomography (PET) tracer for cell radiolabeling that can enable imaging techniques to help better understand cell trafficking in various diseases. Although several groups have synthetized this compound for use in preclinical studies, there is no available data regarding the production of [89 Zr]Oxinate4 for human use. In this report, we describe the detailed production of [89 Zr]Oxinate4 under USP <823> and autologous leukocyte radiolabeling under USP <797>. The final product presented high radiochemical purity and stability at 24 h post synthesis (>99%) and passed in all quality control assays required for clinical use. [89 Zr]Oxinate4 did not compromise the white blood cells viability and did not show considerable cellular efflux up to 3 h post labeling. The translation of this technique into human use can provide insight into several disease mechanisms since [89 Zr]Oxinate4 has the potential to label any cell subset of interest.

Keywords: Zr-89; radiopharmaceutical.

PubMed Disclaimer

References

REFERENCES

    1. Hughes DK. Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate. J Nucl Med Technol. 2003;31:196-201.
    1. Froelich JW, Swanson D. Imaging of inflammatory processes with labeled cells. Semin Nucl Med. 1984;14(2):128-140.
    1. Datz FL. Infection imaging. Semin Nucl Med. 1994;24(2):89-91.
    1. Roca M, de Vries EF, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with 111In-oxine. Inflammation/infection taskgroup of the European association of nuclear medicine. Eur J Nucl Med Mol Imaging. 2010;37(4):835-841.
    1. Saha GB. Fundamentals of Nuclear Pharmacy. 5th ed. New York: Springer; 2003.

LinkOut - more resources